German Customers' experience with Idylla GeneFusion
Idylla™ GeneFusion: Revolutionary Precision Testing for Gene Rearrangements
Bieke Van Dorst, Senior Scientist Biocartis
A comparison of different technologies for genefusion detection – workflow optimization for routine diagnostics
Dr. rer. nat. Janna Siemanowski, Molecular pathological diagnostics, University of Cologne, Germany
Automated Idylla™ GeneFusion test as fast pre-screening method in routine diagnostics – status quo and quo vadis?
Dr. rer. physiol. Melanie Demes, Molecular pathological center, Goethe University Frankfurt, Germany
Idylla™ GeneFusion prototype and the detection of rare fusion partners via expression imbalance
Dr. med. Verena Tischler, Institute of pathology, University hospital Bonn, Germany
Disclaimer
This information concerns a use that has not been approved or cleared by the Food and Drug Administration.
The opinions and conclusions expressed in the following publications are those of the individual authors and do not necessarily reflect the views and opinions of Biocartis and/or its employees.